Pharmaceutical Society of Australia
From 1 February 2021 the majority of prescriptions for supply under the PBS and the RPBS must describe the medicine by active ingredient name to be eligible for subsidy.
Pharmaceutical Society of Australia (PSA) National President Associate Professor Chris Freeman said while current pharmacy workflows or processes largely won’t change, pharmacists should continue talking with consumers about their medicines active ingredient names where possible.
“Pharmacists have an important role to play when it comes to explaining to patients why their prescriptions may look different,” he said.
“When these changes come into effect it is critical that pharmacy staff are prepared to have the necessary conversations with patients and continue to provide information about the brand options available to them.